Patents by Inventor Jack Arbiser

Jack Arbiser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solenopsin a, b and analogs and as novel angiogenesis inhibitors
    Publication number: 20050038071
    Abstract: The present invention relates to solenopsin A and its analogs for use as angiogenesis inhibitors. The present compounds unexpectedly exhibit good activity as angiogenesis inhibitors, which find use as antitumor/anticancer agents as well as to treat a number of conditions or disease states in which angiogenesis is a factor.
    Type: Application
    Filed: January 24, 2003
    Publication date: February 17, 2005
    Inventors: J. Bowen, Jack Arbiser, David Whitmire, M. Furness
  • Treatment of tuberous sclerosis associated neoplasms
    Publication number: 20040077661
    Abstract: The present invention relates to the use of PDGF receptor tyrosine kinase or bcr-abl tyrosine kinase inhibitors, especially of N-phenyl-2-pyrimidine-amine derivatives of formula I, 1
    Type: Application
    Filed: September 4, 2003
    Publication date: April 22, 2004
    Inventor: Jack Arbiser
  • Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
    Publication number: 20030027830
    Abstract: The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize, exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also relates to the use of chalcone and its analogs as antitumor/anticancer agents and to treat a number of conditions or disease states in which angiogenesis is a factor, incluidng angiongenic skin diseases such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, lymphangiogenesis, among numerous others, as well as chronic inflammatory disease such as arthritis.
    Type: Application
    Filed: July 18, 2002
    Publication date: February 6, 2003
    Applicant: University of Georgia Research Foundation, Inc.
    Inventors: J. Phillip Bowen, Thomas Philip Robinson, Tedman Ehlers, David Goldsmith, Jack Arbiser
  • Chalcone and its analogs as agents for the inhibition of angiogensis and related disease states
    Patent number: 6462075
    Abstract: The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize, exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also relates to the use of chalcone and its analogs as antitumor/anticancer agents and to treat a number of conditions or disease states in which angiogenesis is a factor, incluidng angiongenic skin diseases such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, lymphangiogenesis, among numerous others, as well as chronic inflammatory disease such as arthritis.
    Type: Grant
    Filed: December 26, 2000
    Date of Patent: October 8, 2002
    Assignees: The University of Georgia Research Foundation, Inc., Emory University
    Inventors: J. Phillip Bowen, Thomas Phillip Robinson, Tedman Ehlers, David Goldsmith, Jack Arbiser
  • Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
    Publication number: 20020040029
    Abstract: The present invention relates to chalcone and chalcone derivatives and analogs which are useful as angiogenesis inhibitors. The present compounds, which are inexpensive to synthesize, exhibit unexpectedly good activity as angiogenesis inhibitors. The present invention also relates to the use of chalcone and its analogs as antitumor/anticancer agents and to treat a number of conditions or disease states in which angiogenesis is a factor, including angiongenic skin diseases such as psoriasis, acne, rosacea, warts, eczema, hemangiomas, lymphangiogenesis, among numerous others, as well as chronic inflammatory disease such as arthritis.
    Type: Application
    Filed: December 26, 2000
    Publication date: April 4, 2002
    Inventors: J. Phillip Bowen, Thomas Philip Robinson, Tedman Ehlers, David Goldsmith, Jack Arbiser